Login
Home
Charts
Search
Watchlist
Products

ERIS Lifesciences Ltd

ERIS·NSE
₹1,271.20-1.86%Tue, 22 Sept '26 15:57
Industry:Pharma - Formulators
Indices:

ERIS Lifesciences Ltd

ERIS
NSE
₹1,271.20
-1.86%
|Tue, 22 Sept '26 15:57
SOICxStockScans Reports
Industry
Pharma - Formulators
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹17,739Cr
Close
Close Price
₹1,280.00
Industry
Industry
Pharma - Formulators
PE
Price To Earnings
27.22
PS
Price To Sales
5.49
Revenue
Revenue
₹3,230Cr
Rev Gr TTM
Revenue Growth TTM
9.59%
PAT Gr TTM
PAT Growth TTM
62.03%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
505486551720741727705773792807757873
Growth YoY
Revenue Growth YoY%
9.714.936.854.246.749.628.07.46.911.07.313.0
Expenses
ExpensesCr
324311403470477477453496504526483577
Operating Profit
Operating ProfitCr
181176148250265250252277288282274296
OPM
OPM%
35.936.126.934.735.734.435.835.836.434.936.233.9
Other Income
Other IncomeCr
3415254843-1712
Interest Expense
Interest ExpenseCr
161833605957544950494647
Depreciation
DepreciationCr
424654768081777169707072
PBT
PBTCr
12611677116129116129161173145159179
Tax
TaxCr
414-326332927363837-12036
PAT
PATCr
12210180909687102125134109279143
Growth YoY
PAT Growth YoY%
2.51.229.6-4.4-21.2-14.228.439.739.625.0172.714.6
NPM
NPM%
24.220.914.512.413.012.014.516.217.013.536.916.4
EPS
EPS₹
9.17.55.26.16.76.26.98.78.87.320.610.3
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
505486551720741727705773792807757873
Growth YoY
Revenue Growth YoY%
9.714.936.854.246.749.628.07.46.911.07.313.0
Expenses
ExpensesCr
324311403470477477453496504526483577
Operating Profit
Operating ProfitCr
181176148250265250252277288282274296
OPM
OPM%
35.936.126.934.735.734.435.835.836.434.936.233.9
Other Income
Other IncomeCr
3415254843-1712
Interest Expense
Interest ExpenseCr
161833605957544950494647
Depreciation
DepreciationCr
424654768081777169707072
PBT
PBTCr
12611677116129116129161173145159179
Tax
TaxCr
414-326332927363837-12036
PAT
PATCr
12210180909687102125134109279143
Growth YoY
PAT Growth YoY%
2.51.229.6-4.4-21.2-14.228.439.739.625.0172.714.6
NPM
NPM%
24.220.914.512.413.012.014.516.217.013.536.916.4
EPS
EPS₹
9.17.55.26.16.76.26.98.78.87.320.610.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6057508569821,0741,2121,3471,6852,0092,8943,1293,230
Growth
Revenue Growth%
10.923.914.214.89.412.811.225.119.244.08.29.6
Expenses
ExpensesCr
4354805346377067818621,1481,3341,8762,0092,090
Operating Profit
Operating ProfitCr
1702693223453684314855376751,0171,1201,140
OPM
OPM%
28.135.937.635.134.335.536.031.933.635.135.835.3
Other Income
Other IncomeCr
-3025263215926112418-9-11
Interest Expense
Interest ExpenseCr
0111232242685231193191
Depreciation
DepreciationCr
20232636504365117183315280281
PBT
PBTCr
121270312317331395442405431489639657
Tax
TaxCr
52417263539363034114-9-9
PAT
PATCr
116247295291297355406374397375648666
Growth
PAT Growth%
29.6113.219.6-1.31.819.814.3-7.86.1-5.772.862.0
NPM
NPM%
19.132.934.529.627.629.330.122.219.812.920.720.6
EPS
EPS₹
8.417.921.421.121.626.229.928.128.825.945.347.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
6057508569821,0741,2121,3471,6852,0092,8943,1293,230
Growth
Revenue Growth%
10.923.914.214.89.412.811.225.119.244.08.29.6
Expenses
ExpensesCr
4354805346377067818621,1481,3341,8762,0092,090
Operating Profit
Operating ProfitCr
1702693223453684314855376751,0171,1201,140
OPM
OPM%
28.135.937.635.134.335.536.031.933.635.135.835.3
Other Income
Other IncomeCr
-3025263215926112418-9-11
Interest Expense
Interest ExpenseCr
0111232242685231193191
Depreciation
DepreciationCr
20232636504365117183315280281
PBT
PBTCr
121270312317331395442405431489639657
Tax
TaxCr
52417263539363034114-9-9
PAT
PATCr
116247295291297355406374397375648666
Growth
PAT Growth%
29.6113.219.6-1.31.819.814.3-7.86.1-5.772.862.0
NPM
NPM%
19.132.934.529.627.629.330.122.219.812.920.720.6
EPS
EPS₹
8.417.921.421.121.626.229.928.128.825.945.347.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
014141414141414141414
Reserves
ReservesCr
3025538481,1371,2831,5631,8942,1822,5732,8413,889
Current Liabilities
Current LiabilitiesCr
71762253061651672004432,5321,3852,077
Non Current Liabilities
Non Current LiabilitiesCr
25603497991911641,0031,2862,3801,393
Total Liabilities
Total LiabilitiesCr
3987271,4601,5541,5521,8352,2723,6677,0407,0367,366
Current Assets
Current AssetsCr
2372162995824804676277652,3021,2261,540
Non Current Assets
Non Current AssetsCr
1615111,1619721,0731,3681,6452,9034,7385,8105,826
Total Assets
Total AssetsCr
3987271,4601,5541,5521,8352,2723,6677,0407,0367,366
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
014141414141414141414
Reserves
ReservesCr
3025538481,1371,2831,5631,8942,1822,5732,8413,889
Current Liabilities
Current LiabilitiesCr
71762253061651672004432,5321,3852,077
Non Current Liabilities
Non Current LiabilitiesCr
25603497991911641,0031,2862,3801,393
Total Liabilities
Total LiabilitiesCr
3987271,4601,5541,5521,8352,2723,6677,0407,0367,366
Current Assets
Current AssetsCr
2372162995824804676277652,3021,2261,540
Non Current Assets
Non Current AssetsCr
1615111,1619721,0731,3681,6452,9034,7385,8105,826
Total Assets
Total AssetsCr
3987271,4601,5541,5521,8352,2723,6677,0407,0367,366

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1332002352232713753782924861,065538
Investing Cash Flow
Investing Cash FlowCr
-45-184-590-5123-323-320-982-1,855-80-369
Financing Cash Flow
Financing Cash FlowCr
-84-24363-221-335-82-456881,380-881-314
Net Cash Flow
Net Cash FlowCr
4-88-360-3014-211104-145
Free Cash Flow
Free Cash FlowCr
109151210186125350258-550357910241
CFO To PAT
CFO To PAT%
114.781.279.576.691.5105.793.278.0122.4284.383.1
CFO To EBITDA
CFO To EBITDA%
78.074.472.964.773.687.278.054.472.0104.748.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
1332002352232713753782924861,065538
Investing Cash Flow
Investing Cash FlowCr
-45-184-590-5123-323-320-982-1,855-80-369
Financing Cash Flow
Financing Cash FlowCr
-84-24363-221-335-82-456881,380-881-314
Net Cash Flow
Net Cash FlowCr
4-88-360-3014-211104-145
Free Cash Flow
Free Cash FlowCr
109151210186125350258-550357910241
CFO To PAT
CFO To PAT%
114.781.279.576.691.5105.793.278.0122.4284.383.1
CFO To EBITDA
CFO To EBITDA%
78.074.472.964.773.687.278.054.472.0104.748.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,9278,8575,0048,2079,3677,77911,44319,28717,98617,739
Price To Earnings
Price To Earnings
37.130.416.923.123.120.429.254.829.027.2
Price To Sales
Price To Sales
12.89.04.76.87.04.55.66.75.85.5
Price To Book
Price To Book
12.77.73.95.24.93.54.46.84.64.5
EV To EBITDA
EV To EBITDA
34.825.713.419.019.416.019.021.218.118.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
79.780.982.583.582.679.479.977.979.372.771.771.7
OPM
OPM%
28.135.937.635.134.335.536.031.933.635.135.835.3
NPM
NPM%
19.132.934.529.627.629.330.122.219.812.920.720.6
ROCE
ROCE%
40.047.828.429.625.725.022.414.09.613.513.313.3
ROE
ROE%
38.343.534.325.322.922.521.317.015.413.116.616.6
ROA
ROA%
29.133.920.218.719.119.417.910.25.65.38.88.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
10,9278,8575,0048,2079,3677,77911,44319,28717,98617,739
Price To Earnings
Price To Earnings
37.130.416.923.123.120.429.254.829.027.2
Price To Sales
Price To Sales
12.89.04.76.87.04.55.66.75.85.5
Price To Book
Price To Book
12.77.73.95.24.93.54.46.84.64.5
EV To EBITDA
EV To EBITDA
34.825.713.419.019.416.019.021.218.118.1
Profitability Ratios
Profitability Ratios
GPM
GPM%
79.780.982.583.582.679.479.977.979.372.771.771.7
OPM
OPM%
28.135.937.635.134.335.536.031.933.635.135.835.3
NPM
NPM%
19.132.934.529.627.629.330.122.219.812.920.720.6
ROCE
ROCE%
40.047.828.429.625.725.022.414.09.613.513.313.3
ROE
ROE%
38.343.534.325.322.922.521.317.015.413.116.616.6
ROA
ROA%
29.133.920.218.719.119.417.910.25.65.38.88.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — ERIS Lifesciences Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/as-c99a77d2dfb957aabf98551b.pdf
  • Q4 FY2024 Earnings Call Transcript (Mar 2024, PDF): https://www.stockscans.in/document/7o56rdkgtnphm09lanhmfn8i.pdf
  • Q3 FY2023 Earnings Call Transcript (Dec 2022, PDF): https://www.stockscans.in/document/j6ecy5fo7xw8lhd0p6ffdrj7.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/h935hdbe4uvp4ix9vs6q4t3q.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/sppioiwti1747kfv1qqyprbc.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/s1l0gc8j8l8wq5xeq3d80myq.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/poazqc6tfknpvn38cou3gjsx.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/y0h02a5jzl1gj6if9evgwbce.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/48tvqgaw4narqvjzyzwo27g4.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/cnfrncxuqnuskgsv1wfk8mqw.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/zsfkjsfv9unc1p3xm2qhkdv0.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/x5j7tz7rdy6z5ddp4oenw2xe.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/hlokwgu6htpnkx4aonzasrd0.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/48bd0uoi02cw4wi4u2lyikcj.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/b0p5tc8qtx9xxhglqfklc2os.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/o4tilkp5e3tm2weatw2i46y8.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/1lov2ehjm61p30mryr6byviz.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/o5gitderu3ntqattldp0a2ai.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/8n6wwimkk5zoeeairktb6t1y.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/xu1akur7smhx5qlksws49kfu.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/5jz8ja0qwg2c1rmtkr8eoq1a.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/bar4nojf21kx2c6uu7m4d9bi.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/eevit14z8fhaxq8v3h0adqen.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/3iukbei01gb4qothk9aav01f.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/y15s7b627st89jt6p4ctnq2j.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/0xzsx227a804n2rnz9m3mkrk.pdf

Concall Transcript Summaries — ERIS Lifesciences Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AERIS/transcript-notes/202606/as-c99a77d2dfb957aabf98551b.pdf
  • Q4 FY2024 Concall Transcript Summary (Mar 2024): https://www.stockscans.in/company/NSE%3AERIS/transcript-notes/202403/7o56rdkgtnphm09lanhmfn8i.pdf
  • Q3 FY2023 Concall Transcript Summary (Dec 2022): https://www.stockscans.in/company/NSE%3AERIS/transcript-notes/202212/j6ecy5fo7xw8lhd0p6ffdrj7.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies